Commission Directive 2002/70/EC of 26 July 2002 establishing requirements for the determination of levels of dioxins and dioxin-like PCBs in feedingstuffs (Text with EEA relevance) (repealed) in England
EU Directive 2002/70 · Adopted 26 July 2002 · Extends to United Kingdom
Commission Directive 2002/70/EC
of 26 July 2002
establishing requirements for the determination of levels of dioxins and dioxin-like PCBs in feedingstuffs
(Text with EEA relevance) (repealed)
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annotations to the whole text
Textual amendments
Contents
- 1Article 1 Repealed
- 2Article 2 Repealed
- 3Article 3 Repealed
- 4Article 4 Repealed
- 5Article 5 Repealed
- Annex I: METHODS OF SAMPLING FOR OFFICIAL CONTROL OF THE LEVELS OF DIOXINS (PCDD/PCDF) AND THE DETERMINATION OF DIOXIN-LIKE PCBs IN CERTAIN FEEDINGSTUFFS Repealed
- 1Purpose and scope Repealed
- 2Compliance of the lot or sublot with the specification Repealed
- Annex II: SAMPLE PREPARATION AND REQUIREMENTS FOR METHODS OF ANALYSIS USED IN OFFICIAL CONTROL OF THE LEVELS OF DIOXINS (PCDD/PCDF) AND THE DETERMINATION OF DIOXIN-LIKE PCBs IN CERTAIN FEEDINGSTUFFS Repealed
- 1Objective and field of application Repealed
- 2Background Repealed
- 3Quality assurance requirements to be complied with for sample preparation Repealed
- 4Requirements for laboratories Repealed
- 5Requirements for the analytical procedures for dioxins and dioxin-like PCBs Repealed
- 6Specific requirements for GC/MS methods to be complied with for screening or confirmatory purposes Repealed
- Screening methods of analysis Repealed
- 7.1Introduction Repealed
- Screening approach Repealed
- Quantitative approach Repealed
- 7.2Requirements for methods of analysis used for screening Repealed
- 7.3Specific requirements for cell-based bioassays Repealed
- 7.4Specific requirements for kit-based bioassays Repealed
- 8Reporting of results Repealed
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1Purpose and scopeF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2Compliance of the lot or sublot with the specificationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1Objective and field of applicationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2BackgroundF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3Quality assurance requirements to be complied with for sample preparationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4Requirements for laboratoriesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5Requirements for the analytical procedures for dioxins and dioxin-like PCBsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6Specific requirements for GC/MS methods to be complied with for screening or confirmatory purposesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7.1IntroductionF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Screening approach
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Quantitative approach
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7.2Requirements for methods of analysis used for screeningF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7.3Specific requirements for cell-based bioassaysF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7.4Specific requirements for kit-based bioassaysF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8Reporting of resultsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .